PNRI-299
PNRI-299 is a selective AP-1 transcription inhibitor with an IC50 of 20 uM. PNRI-299 is a selective APE/Ref-1 inhibitor. PNRI-299 has no effect on NF-κB transcription or thioredoxin (up to 200 uM) . PNRI-299 significantly reduces airway eosinophil infiltration, mucus hypersecretion, edema, and IL-4 levels in a mouse asthma model[1][2][3].
Product Specifications
CAS Number
550368-41-7
UNSPSC
12352005
Target
Interleukin Related
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/PNRI-299.html
Solubility
10 mM in DMSO
Smiles
O=C1N2N(C(C(NCC3=CC=CC=C3)=O)=CC(C2)=O)C(N1C4=CC(C#N)=CC=C4)=O
Molecular Formula
C21H15N5O4
Molecular Weight
401.37
References & Citations
[1]Nguyen C, et al. Chemogenomic identification of Ref-1/AP-1 as a therapeutic target for asthma. Proc Natl Acad Sci U S A. 2003 Feb 4;100 (3) :1169-73.|[2]Souza DG, et al. NF-kappaB plays a major role during the systemic and local acute inflammatory response following intestinal reperfusion injury. Br J Pharmacol. 2005 May;145 (2) :246-54.|[3]Sun Yang, et al. Apurinic/apyrimidinic endonuclease/redox effector factor-1 (APE/Ref-1) : a unique target for the prevention and treatment of human melanoma. Antioxid Redox Signal. 2009 Mar;11 (3) :639-50.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IL-4
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
9-47118 Set
Human Glomerular PrimaCell™: Normal Glomerular Endothelial Cells Growth Supplements with Serum (for 500 mL medium)
Sign In for Pricing
View Details